Grisham RN, Van Nieuwenhuysen E, Santin AD, D'Hondt V, et al. Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201. Gynecol Oncol 2026;213:59-67.
PMID: 42748602